ChemoTech’s Animal Care Celebrates Record-Breaking Month with Order Intake of 200,000 USD in April

Scandinavian ChemoTech is proud to announce a record-breaking performance in April, with order intake near the total for the entire first quarter of the year. This achievement marks a significant milestone and sets a strong tone for the beginning of Q2.

“We are thrilled with the momentum we have seen as we move into the second quarter," said Mohan Frick, CEO. "Nearing our Q1 order volume in just one month is a testament to the hard work of our team and the trust our customers place in Tumor-Specific Electroporation (TSE)."

While the company is optimistic about the trajectory for Q2, the sales forecast for the remainder of the quarter is still uncertain. “While we are encouraged by this strong start, it’s too early to project how the rest of the quarter will unfold,” said Ann Ohlsson, Head of finance.

This disclosure contains information that ChemoTech is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 01-05-2025 06:15 CET.